3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
70
Neoplasm Metastasis
11
Prostatic Neoplasms
9
Pain
8
Osteoporosis
8
Multiple Myeloma
5
Humoral Hypercalcemia Of Malignancy
4
Triple Negative Breast Neoplasms
3
Bone Diseases, Metabolic
3
Neoplasms
2
Lung Neoplasms
2
Breast Neoplasms, Male
2
Bone Neoplasms
2
Bone Diseases
2
Renal Insufficiency
1
Ovarian Neoplasms
1
Neovascularization, Pathologic
1
Neoplastic Cells, Circulating
1
Neoplasms by Site
1
Neoplasm Micrometastasis
1
Metastatic Breast Cancer With Bone Involvement
1
Hereditary Breast and Ovarian Cancer Syndrome
1
Fractures, Bone
1
Fatigue
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Ductal, Breast
1
Breast Diseases
1
Breast Cancer Metastatic
1
Interventions
Zoledronic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Metastatic Breast Cancer With Bone Involvement
×
Zoledronic Acid
×
Breast
×
Clear all
NCT01344967
2015-06-23
SuBDuE
University Health Network, Toronto
Phase 2/3
Completed
21 enrolled